A New Discovery: Successful Cancer & HIV+ Reversal Method Through DNA Repair, Gene Expression Modulation & Simplified Immunomodulation Therapeutics Available & Will Exceed US$100 Billion by 2019

Jul 20, 2015, 09:00 ET from HA EXIM LTD

KUALA LUMPUR, Malaysia, July 20, 2015 /PRNewswire/ --

A novel therapy method successfully reversed chronic and terminal diseases, says HA EXIM.

A non-toxic broad-spectrum DNA Repair & Immunomodulation Therapeutics successfully reversed cancer conditions and HIV+ cases in human beings. The anti-cancer and anti-HIV treatment method gives new hope to 14.1 million new cancer cases and 35 million people living with HIV/AIDS worldwide.

Simplified Immunomodulation and DNA Repair Mechanisms enable reprogramming of DNA structure and function, which leads to natural termination of carcinomas and sarcomas as well as various types of drug resistant viruses such as HIV; this overcomes the challenges encountered by ongoing complex cancer research to mapping natural compounds that can act on hundreds of receptor pathways target such as: Notch-1; Notch-2; VEGF; JAK-STAT; HEDGEHOG; IL-1R; EGFR; EGFR2; PDGF.

Chemotherapy and radiation therapy kill healthy cells while targeting cancer cells. This new treatment method is a non-invasive and non-radiation cancer therapy which uses a combination of plant-based compounds at the right particle size, a list of complex enzymes and amino acids, and autophagy inducement substances and protocols to induce apoptosis in cancer cells while repairing cells and epigenetic restructuring of human DNA.

Focusing on gene modulation and repair, the treatment supports the body's natural ability to heal itself. The treatment has been available privately for two years with a phenomenal 100% success rate with no negative side effects reported. The common types of cancer are such as: Breast Cancer; Colorectal Cancer; Bladder Cancer; Lung Cancer; Liver Cancer; Prostate Cancer, etc.

In November 2014 a thirty-three year-old patient in Kuala Lumpur who had been diagnosed with Stage 4 Nasopharyngeal Cancer began the new treatment protocol after all conventional cancer treatments had failed. At the end of the treatment period of 240 days, a PET-scan indicated that there was no trace of new, metastatic, nor residual cancer cells, and the patient's oncologist declared that he was cancer-free.

This medical discovery is a game changer. It was recently reported that the cancer drug market just hit USD$100 billion in annual sales and could jump 50% in four years.

HA EXIM is an organisation that develops groundbreaking scientific research and development and game changing solutions in the following areas: Biosciences, Medical, Agriculture and Energy.

For more information please contact:

Scientific Explanation, Challenge & Treatment
Investor Relations & Investment Opportunities